Skip to main content
OpenTrials

Clinical trial condition

Homozygous Familial Hypercholesterolemia

Explore clinical trials studying Homozygous Familial Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

57 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Homozygous Familial Hypercholesterolemia trial results

Completed

Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

NCT00943306

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +11 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Robarts Research Institute London, Ontario, Canada
  • Lipid Clinic and University of Montreal Community Genomic Medicine Center Chicoutimi, Quebec, Canada
View Trial Details
Completed

A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)

NCT00730236

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • Robarts Research Institute London, Ontario, Canada
  • Lipid Clinic and University of Montreal Community Genomic Medicine Center Chicoutimi, Quebec, Canada
View Trial Details
Completed

A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

NCT02434497

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Research Site Brussels (Woluwé-St-Lambert), Belgium
  • Research Site Chicoutimi, Quebec, Canada
  • Research Site Copenhagen, Denmark
  • Research Site Halfa, Israel
View Trial Details
Completed

An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia

NCT00694109

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, +14 more
Locations
  • Mission Viejo, California, United States
  • Newport Beach, California, United States
  • Bridgeport, Connecticut, United States
  • Melbourne, Florida, United States
View all 33 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia

NCT02226198

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Research Site Brussels (Woluwé-St-Lambert), Belgium
  • Research Site Chicoutimi, Quebec, Canada
  • Research Site København Ø, Denmark
  • Research Site Haifa, Israel
View Trial Details

Related conditions